Inference of dynamic biological networks based on responses to drug perturbations
暂无分享,去创建一个
Ranadip Pal | Noah Berlow | Charles Keller | Lara E. Davis | Noah E. Berlow | R. Pal | C. Keller | L. Davis
[1] B. Druker,et al. Molecularly targeted therapy: have the floodgates opened? , 2004, The oncologist.
[2] J. Mesirov,et al. Chemosensitivity prediction by transcriptional profiling , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[3] Jae K. Lee,et al. A strategy for predicting the chemosensitivity of human cancers and its application to drug discovery , 2007, Proceedings of the National Academy of Sciences.
[4] Howard A. Fine,et al. Predicting in vitro drug sensitivity using Random Forests , 2011, Bioinform..
[5] Laura Tolosi,et al. Predicting drug susceptibility of non-small cell lung cancers based on genetic lesions. , 2009, The Journal of clinical investigation.
[6] Ranadip Pal,et al. Analyzing pathway design from drug perturbation experiments , 2012, 2012 IEEE Statistical Signal Processing Workshop (SSP).
[7] Aniruddha Datta,et al. Intervention in context-sensitive probabilistic Boolean networks , 2005, Bioinform..
[8] Stuart A. Kauffman,et al. The origins of order , 1993 .
[9] T. Zhou,et al. A Relative Variation-Based Method to Unraveling Gene Regulatory Networks , 2012, PloS one.
[10] S. Ramaswamy,et al. Systematic identification of genomic markers of drug sensitivity in cancer cells , 2012, Nature.
[11] Mark R. Green,et al. Targeting targeted therapy. , 2004, The New England journal of medicine.
[12] S. Morrison,et al. Heterogeneity in Cancer: Cancer Stem Cells versus Clonal Evolution , 2009, Cell.
[13] N. D. Clarke,et al. Towards a Rigorous Assessment of Systems Biology Models: The DREAM3 Challenges , 2010, PloS one.
[14] C. Sander,et al. Models from experiments: combinatorial drug perturbations of cancer cells , 2008, Molecular systems biology.
[15] J. Sklar,et al. Molecular Tumor Profiling for Prediction of Response to Anticancer Therapies , 2011, Cancer journal.
[16] Kevan M Shokat,et al. Features of selective kinase inhibitors. , 2005, Chemistry & biology.
[17] Hidde de Jong,et al. Modeling and Simulation of Genetic Regulatory Systems: A Literature Review , 2002, J. Comput. Biol..
[18] Ranadip Pal,et al. A new approach for prediction of tumor sensitivity to targeted drugs based on functional data , 2013, BMC Bioinformatics.
[19] Ranadip Pal,et al. A Kinase Inhibition Map Approach for Tumor Sensitivity Prediction and Combination Therapy Design for Targeted Drugs , 2011, Pacific Symposium on Biocomputing.
[20] Adam A. Margolin,et al. The Cancer Cell Line Encyclopedia enables predictive modeling of anticancer drug sensitivity , 2012, Nature.
[21] C. Sawyers,et al. Targeted cancer therapy , 2004, Nature.
[22] Ranadip Pal,et al. Context-Sensitive Probabilistic Boolean Networks: Steady-State Properties, Reduction, and Steady-State Approximation , 2010, IEEE Transactions on Signal Processing.
[23] Tong Zhou,et al. BIOINFORMATICS ORIGINAL PAPER , 2022 .
[24] Ranadip Pal,et al. Characterizing the Effect of Coarse-Scale PBN Modeling on Dynamics and Intervention Performance of Genetic Regulatory Networks Represented by Stochastic Master Equation Models , 2010, IEEE Transactions on Signal Processing.
[25] Julio Saez-Rodriguez,et al. Identifying Drug Effects via Pathway Alterations using an Integer Linear Programming Optimization Formulation on Phosphoproteomic Data , 2009, PLoS Comput. Biol..
[26] John P. Overington,et al. Can we rationally design promiscuous drugs? , 2006, Current opinion in structural biology.